WARF Signs License Agreement With Pfizer For Human Embryonic Stem Cells
Pfizer Inc., a major biopharmaceutical company, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin-Madison, announced May 5 that they have signed a license for human embryonic stem (hES) cell patents for the development of new drug therapies. The WARF license provides Pfizer the rights to work with hES cells for drug research and discovery.
[Read the full article here]Related News:
Pfizer, WARF sign license agreement for human embryonic stem cell patents
Pfizer signs license for stem cell research
WARF Loses Round In Stem Cell Patent Battle